Sparks D L, Hunsaker J C, Slevin J T, DeKosky S T, Kryscio R J, Markesbery W R
Sanders-Brown Center on Aging, Department of Pathology, University of Kentucky, Lexington.
Ann Neurol. 1992 Jun;31(6):611-20. doi: 10.1002/ana.410310608.
Neurotransmitter markers for acetylcholine, serotonin (5-HT), and dopamine (DA) were measured in autopsied human nucleus basalis of Meynert (nbM) from nondemented individuals without heart disease (non-HD) (age range, 4-84 years; n = 77), nondemented individuals with heart disease (HD) (age range, 57-92 years; n = 23), and individuals with Alzheimer's disease (AD) (age range, 59-92 years; n = 22). No significant differences in any chemical marker were found between age-matched HD and non-HD individuals. The activities of choline acetyltransferase (ChAT) and acetylcholinesterase (AChE), and [3H]spiperone binding were regionally distributed within the nbM in control (non-HD) subjects less than 54 years of age. The activity of AChE, 5-[3H]HT binding, and the content of homovanillic acid (HVA), 5-hydroxyindoleacetic acid (5-HIAA), and 5-HT were regionally distributed in the nbM in non-HD, HD, and AD subjects more than 54 years of age. The binding of [3H]spiperone was regionally distributed in the nbM in HD and AD subjects more than 54 years of age, only. Activity of ChAT and AChE, content of 5-HT, 5-HIAA, and DA, binding of 5-[3H]HT, and the turnover number for DA (ratio of HVA/DA) all decreased with increasing age in the non-HD control population. The content of HVA, binding of [3H]spiperone, and the turnover number for 5-HT (ratio of 5-HIAA/5-HT) did not change with increasing age. Significant reductions in ChAT and AChE activities were found in AD nbM compared with postmortem interval- and age-matched HD and non-HD individuals. The reduction of 5-HT and 5-HIAA content and [3H]spiperone binding in individuals with AD of all ages suggests a loss of functional serotonergic innervation of the nbM. Dopaminergic synaptic markers were less affected in AD nbM, although turnover numbers for both DA and 5-HT were increased in AD. Receptor upregulation in response to presynaptic deficits did not occur for DA or 5-HT.
在无心脏病的非痴呆个体(非HD)(年龄范围4 - 84岁;n = 77)、有心脏病的非痴呆个体(HD)(年龄范围57 - 92岁;n = 23)以及阿尔茨海默病(AD)患者(年龄范围59 - 92岁;n = 22)的梅纳特基底核(nbM)尸检样本中,检测了乙酰胆碱、5-羟色胺(5-HT)和多巴胺(DA)的神经递质标志物。在年龄匹配的HD和非HD个体之间,未发现任何化学标志物有显著差异。在年龄小于54岁的对照(非HD)受试者中,胆碱乙酰转移酶(ChAT)和乙酰胆碱酯酶(AChE)的活性以及[³H]司哌罗宁结合在nbM区域内呈分布状态。在年龄大于54岁的非HD、HD和AD受试者中,AChE活性、5-[³H]HT结合以及高香草酸(HVA)、5-羟吲哚乙酸(5-HIAA)和5-HT的含量在nbM区域内呈分布状态。仅在年龄大于54岁的HD和AD受试者中,[³H]司哌罗宁结合在nbM区域内呈分布状态。在非HD对照人群中,ChAT和AChE活性、5-HT、5-HIAA和DA的含量、5-[³H]HT结合以及DA的转换数(HVA / DA比值)均随年龄增长而降低。HVA含量、[³H]司哌罗宁结合以及5-HT的转换数(5-HIAA / 5-HT比值)并未随年龄增长而变化。与死后间隔时间和年龄匹配的HD及非HD个体相比,AD的nbM中ChAT和AChE活性显著降低。各年龄段AD患者中5-HT和5-HIAA含量以及[³H]司哌罗宁结合的降低表明nbM功能性5-羟色胺能神经支配丧失。AD的nbM中多巴胺能突触标志物受影响较小,尽管AD中DA和5-HT的转换数均增加。DA或5-HT并未因突触前缺陷而发生受体上调。